GENE ONLINE|News &
Opinion
Blog

IPO
IPO BeiGene
BeiGene launches IPO on Shanghai’s STAR market to raise $3B
2021-12-03
Feature Hong Kong
Experts Discuss What’s Next for Healthcare Innovation and Investment at ASGH
2021-12-02
China IPO
Chinese Vaccine Maker Raises $240 Million in Hong Kong Debut
2021-11-08
China IPO
Shanghai Startup Lands $325 Million Nasdaq IPO to Advance Phase 3 Assets
2021-11-02
China IPO
Shanghai Startup Poised for $325M IPO on Nasdaq
2021-10-21
Asia-Pacific Series C Funding
South Korea’s D&D Pharmatech Secures $51M Series C, Eyes 2022 IPO
2021-10-20
1 2
LATEST
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top